RNS Number : 5284F
Albert Technologies Ltd
29 October 2018
 

 


29 October 2018

 

Albert Technologies Ltd.

("Albert Technologies" or the "Company")

Grant of Options to Directors

 

Albert Technologies (AIM: ALB) announces that, it has conditionally granted options over ordinary shares of NIS 0.1 in the Company ("Options") to a number of board directors. Under Israeli Law, the grant of options to board directors requires the ratification of shareholders. As such a circular including a Notice of General Meeting will be posted to shareholders and a further announcement made in due course. The Options have been conditionally granted as follows:

 

Yoram Freund, Chief Financial Officer of the Company, has been granted Options to purchase up to 202,747 ordinary shares at an exercise price of 26p per share, based on the average closing price of the Ordinary Shares during the 30 trading day period up to and including 17 October 2018, the date immediately prior to grant. The options vest over four years, 50% on 1 August 2020, 25% on 1 August 2021 and 25% on 1 August 2022, and will be fully vested on 1 August 2022.

 

Lisa Gordon, Chairman of the Company, has been granted Options to purchase up to 56,250 ordinary shares at an exercise price equal to 20p, being the closing price of ordinary shares on 17 October 2018, the date immediately prior to grant. The Options vest over three years, one-third upon each anniversary from 6 September 2018 - the date of our Annual General Meeting, and will be fully vested on 6 September 2021.

 

Robert Norman, Non-executive Director of the Company, has been granted Options to purchase up to 30,000 ordinary shares at an exercise price equal to 20p, being the closing price of ordinary shares on 17 October 2018, the date immediately prior to grant. The options vest over three years, one-third upon each anniversary from 1 April 2018 - the date Robert engaged with the Company for advising the Board, and will be fully vested on 1 April 2021.

 

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

 

Albert Technologies Ltd


Or Shani, Chief Executive Officer

Yoram Freund, Chief Financial Officer

 

Tel: +972 3537 7137

Cantor Fitzgerald Europe


Marc Milmo

Catherine Leftley

 

+44 (0)20 7894 7000

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Company Director/PDMR

Lisa Gordon

Chairman

Robert Norman

Non-executive Director

Yoram Freund

Chief Financial Officer

2

 

Reason for the notification

 

a)

 

Position/status

 

 

See 1 (a) above for all positions, all classified as PDMRs of the Company

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Albert Technologies Limited

b)

 

LEI

 

 

213800AL8MDWHCB8W888

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of NIS 0.1



ISIN:  IL0011354904/ALB

 


b)

 

Nature of the transaction

 

 

Conditional grant of share options over ordinary shares

 

c)

 

Price(s) and volume(s)


Exercise price: 94p per Ordinary Share

 

Volumes:

NAME

VOLUME

EXERCISE PRICE

Lisa Gordon

56,250

20p

Robert Norman

30,000

20p

Yoram Freund

202,747

26p








d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

18 October 2018

f)

 

Place of the transaction

 

 

Off market

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKCDDKBDDFKB